Vanguard Group
NMTR

Vanguard Group’s 9 Meters Biopharma NMTR Stock Holding History

Vanguard Group’s Portfolio NMTR Stock Details NMTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-619,829
Closed -$417K – 4622
2023
Q2 		$417K Sell
619,829
-8,477
-1% -$7.5K ﹤0.01% 4168
2023
Q1 		$873K Hold
628,306
– – ﹤0.01% 3958
2022
Q4 		$792K Buy
628,306
+256
+0% +$584 ﹤0.01% 3982
2022
Q3 		$2.7M Buy
628,050
+52,939
+9% +$262K ﹤0.01% 3618
2022
Q2 		$3M Sell
575,111
-9,795
-2% -$92.3K ﹤0.01% 3627
2022
Q1 		$7.01M Sell
584,906
-7,318
-1% -$99.9K ﹤0.01% 3343
2021
Q4 		$11.6M Buy
592,224
+8,741
+1% +$196K ﹤0.01% 3135
2021
Q3 		$15.2M Buy
583,483
+37,189
+7% +$876K ﹤0.01% 3009
2021
Q2 		$12M Buy
546,294
+96,839
+22% +$2.38M ﹤0.01% 3117
2021
Q1 		$10.5M Buy
449,455
+89,826
+25% +$2.76M ﹤0.01% 3114
2020
Q4 		$6.18M Buy
359,629
+321,347
+839% +$5.36M ﹤0.01% 3258
2020
Q3 		$624K Buy
38,282
+2,523
+7% +$30.6K ﹤0.01% 3769
2020
Q2 		$410K Sell
35,759
-293
-0.8% -$3.3K ﹤0.01% 3813
2020
Q1 		$363K Hold
36,052
– – ﹤0.01% 3738
2019
Q4 		$402K Sell
36,052
-455
-1% -$7.58K ﹤0.01% 3835
2019
Q3 		$781K Sell
36,507
-11,250
-24% -$227K ﹤0.01% 3712
2019
Q2 		$1.11M Buy
47,757
+6,055
+15% +$182K ﹤0.01% 3645
2019
Q1 		$1.61M Buy
41,702
+15,654
+60% +$677K ﹤0.01% 3513
2018
Q4 		$1.2M Buy
26,048
+9,832
+61% +$729K ﹤0.01% 3511
2018
Q3 		$2.21M Buy
16,216
+12,887
+387% +$2.21M ﹤0.01% 3492
2018
Q2 		$1.57M Buy
+3,329
New +$1.22M ﹤0.01% 3564
2017
Q4 		– Sell
-197
Closed -$28K – 4081
2017
Q3 		$28K Buy
197
+10
+5% +$1.56K ﹤0.01% 4047
2017
Q2 		$18K Sell
187
-9
-5% -$1.26K ﹤0.01% 4063
2017
Q1 		$47K Buy
+196
New +$58.8K ﹤0.01% 4029

Other funds holding NMTR

SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
SIS
Strategic Investment Solutions Orland Park, Illinois $437M AUM 30.41% 1-Year Est. Return
RCM
Requisite Capital Management Dallas, Texas $537M AUM 12.29% 1-Year Est. Return
BCMLT
Beacon Capital Management LLC (Tennessee) Franklin, Tennessee $567M AUM 16.01% 1-Year Est. Return
SPIA
Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return
RFA
Register Financial Advisors Atlanta, Georgia $326M AUM 48.38% 1-Year Est. Return

Vanguard Group's NMTR Position: Q3 2023 in Review

Vanguard Group sold out of 9 Meters Biopharma (NMTR) in Q3 2023, closing a stake of 619,829 shares — an estimated $417K sold.

Vanguard Group first reported a position in NMTR in Q1 2017 and held it in 24 quarters. The position peaked at $15.2M in Q3 2021. 6 funds tracked by Wall St. Rank hold NMTR as of Q3 2023.

  • Vanguard Group reported no remaining 9 Meters Biopharma position as of Q3 2023 after selling out during the quarter.
  • Vanguard Group sold 619,829 9 Meters Biopharma shares in Q3 2023, an estimated $417K.
  • Vanguard Group first reported a position in 9 Meters Biopharma in Q1 2017 and held it in 24 quarters.
  • Vanguard Group's 9 Meters Biopharma position peaked at $15.2M in Q3 2021.
  • 6 funds tracked by Wall St. Rank held 9 Meters Biopharma as of Q3 2023.

Based on Vanguard Group's 13F filing for Q3 2023, filed 14 Nov 2023.